These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 12429803)
1. Over-expression of p45(SKP2) in Kaposi's sarcoma correlates with higher tumor stage and extracutaneous involvement but is not directly related to p27(KIP1) down-regulation. Penin RM; Fernandez-Figueras MT; Puig L; Rex J; Ferrandiz C; Ariza A Mod Pathol; 2002 Nov; 15(11):1227-35. PubMed ID: 12429803 [TBL] [Abstract][Full Text] [Related]
2. Decreased immunoreactivity for cell-cycle regulator p27(Kip1) in Kaposi's sarcoma correlates with higher stage and extracutaneous involvement. Fernández-Figueras MT; Puig L; Penín RM; Mate JL; Bigatà X; Ariza A J Pathol; 2000 Aug; 191(4):387-93. PubMed ID: 10918213 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells. Lin R; Wang TT; Miller WH; White JH Endocrinology; 2003 Mar; 144(3):749-53. PubMed ID: 12586749 [TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase. Kamura T; Hara T; Matsumoto M; Ishida N; Okumura F; Hatakeyama S; Yoshida M; Nakayama K; Nakayama KI Nat Cell Biol; 2004 Dec; 6(12):1229-35. PubMed ID: 15531880 [TBL] [Abstract][Full Text] [Related]
5. Degradation of p27(Kip1) at the G(0)-G(1) transition mediated by a Skp2-independent ubiquitination pathway. Hara T; Kamura T; Nakayama K; Oshikawa K; Hatakeyama S; Nakayama K J Biol Chem; 2001 Dec; 276(52):48937-43. PubMed ID: 11682478 [TBL] [Abstract][Full Text] [Related]
6. Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells. Koga H; Harada M; Ohtsubo M; Shishido S; Kumemura H; Hanada S; Taniguchi E; Yamashita K; Kumashiro R; Ueno T; Sata M Hepatology; 2003 May; 37(5):1086-96. PubMed ID: 12717389 [TBL] [Abstract][Full Text] [Related]
7. Expression of Skp2, a p27(Kip1) ubiquitin ligase, in malignant lymphoma: correlation with p27(Kip1) and proliferation index. Lim MS; Adamson A; Lin Z; Perez-Ordonez B; Jordan RC; Tripp S; Perkins SL; Elenitoba-Johnson KS Blood; 2002 Oct; 100(8):2950-6. PubMed ID: 12351407 [TBL] [Abstract][Full Text] [Related]
8. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1). Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332 [TBL] [Abstract][Full Text] [Related]
9. Modification of cullin-1 by ubiquitin-like protein Nedd8 enhances the activity of SCF(skp2) toward p27(kip1). Morimoto M; Nishida T; Honda R; Yasuda H Biochem Biophys Res Commun; 2000 Apr; 270(3):1093-6. PubMed ID: 10772955 [TBL] [Abstract][Full Text] [Related]
11. Damage-specific DNA binding protein 1 (DDB1) is involved in ubiquitin-mediated proteolysis of p27Kip1 in response to UV irradiation. Iovine B; Iannella ML; Bevilacqua MA Biochimie; 2011 May; 93(5):867-75. PubMed ID: 21237244 [TBL] [Abstract][Full Text] [Related]
12. [Correlation of Skp2 and P27kip1 protein expression and clinicopathological features of prostate cancer]. Zheng XY; Ding W; Xie LP; Chen ZD Ai Zheng; 2004 Feb; 23(2):215-8. PubMed ID: 14960249 [TBL] [Abstract][Full Text] [Related]
13. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas. Kudo Y; Kitajima S; Sato S; Miyauchi M; Ogawa I; Takata T Cancer Res; 2001 Oct; 61(19):7044-7. PubMed ID: 11585732 [TBL] [Abstract][Full Text] [Related]
14. Association of human CUL-1 and ubiquitin-conjugating enzyme CDC34 with the F-box protein p45(SKP2): evidence for evolutionary conservation in the subunit composition of the CDC34-SCF pathway. Lisztwan J; Marti A; Sutterlüty H; Gstaiger M; Wirbelauer C; Krek W EMBO J; 1998 Jan; 17(2):368-83. PubMed ID: 9430629 [TBL] [Abstract][Full Text] [Related]
15. Skp2 is oncogenic and overexpressed in human cancers. Gstaiger M; Jordan R; Lim M; Catzavelos C; Mestan J; Slingerland J; Krek W Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5043-8. PubMed ID: 11309491 [TBL] [Abstract][Full Text] [Related]
17. Inverse relation between levels of p27(Kip1) and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas. Hershko D; Bornstein G; Ben-Izhak O; Carrano A; Pagano M; Krausz MM; Hershko A Cancer; 2001 May; 91(9):1745-51. PubMed ID: 11335900 [TBL] [Abstract][Full Text] [Related]
18. Expression of p27 and its ubiquitin ligase subunit Skp2 in upper urinary tract transitional cell carcinoma. Langner C; von Wasielewski R; Ratschek M; Rehak P; Zigeuner R Urology; 2004 Sep; 64(3):611-6. PubMed ID: 15351619 [TBL] [Abstract][Full Text] [Related]
19. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. Nakayama K; Nagahama H; Minamishima YA; Matsumoto M; Nakamichi I; Kitagawa K; Shirane M; Tsunematsu R; Tsukiyama T; Ishida N; Kitagawa M; Nakayama K; Hatakeyama S EMBO J; 2000 May; 19(9):2069-81. PubMed ID: 10790373 [TBL] [Abstract][Full Text] [Related]
20. Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate. Shim EH; Johnson L; Noh HL; Kim YJ; Sun H; Zeiss C; Zhang H Cancer Res; 2003 Apr; 63(7):1583-8. PubMed ID: 12670908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]